title: Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.
authors.forename: T
authors.initials: T
authors.lastname: Brodowicz
authors.forename: R
authors.initials: R
authors.lastname: Kotz
authors.forename: C
authors.initials: C
authors.lastname: Wiltschke
authors.forename: C C
authors.initials: CC
authors.lastname: Zielinski
authors.forename: P
authors.initials: P
authors.lastname: Ritschl
mesh_terms: D000671:Amputation, Surgical / Q000706:statistics & numerical data; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005121:Extremities; D006801:Humans; D007371:Interferon-gamma / Q000008:administration & dosage; D008558:Melphalan / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D012509:Sarcoma / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D016019:Survival Analysis; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage
chemical_list: D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D008558:Melphalan